MiNK Therapeutics, Inc.

INKT·NasdaqCM·Healthcare
Compare
10.60−0.19 (−1.76%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.79
Open11.03
Day range10.6011.03
52-week range8.4816.93
Off day high−3.90%
Off 52-week high−37.38%
Volume5.77K
Avg. volume (3M)14.18K
Market cap54.09M
EPS (TTM)-2.39
Forward P/E-4.84
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.45
Shares outstanding5.10M
Short interest1.87% of float
Earnings dateNov 11, 2026
Analyst target42.50
Profit margin0.00%

Against its peers

Compare in full ›
INKT TVGN CHRS APLM ARTV ALXO
Market cap 54.09M 95.87M 131.36M 55.38M 206.32M 188.06M
P/E (TTM) — — — — — —
Forward P/E -4.8 — -1.3 -29.2 -2.1 -2.5
Price/book -3.9 -1.4 2.2 -12.8 0.6 1.4
Dividend yield — — — — — —
1-year change −22.40% −75.61% −42.95% +42.64% +22.67% +15.25%
Today −1.76% −3.38% +5.54% −8.83% +0.48% +5.43%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to MiNK Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Tevogen Bio Holdings Inc.TVGN · Biotechnology 95.87M 5.72 −3.38%
Coherus Oncology, Inc.CHRS · Biotechnology 131.36M 0.8502 +5.54%
Apollomics, Inc.APLM · Biotechnology 55.38M 19.00 −8.83%
Artiva Biotherapeutics, Inc.ARTV · Biotechnology 206.32M 4.2200 +0.48%
ALX Oncology Holdings Inc.ALXO · Biotechnology 188.06M 1.3600 +5.43%
Cardiff Oncology, Inc.CRDF · Biotechnology 67.60M 0.8689 +0.67%
Cellectis S.A.CLLS · Biotechnology 117.86M 1.1700 +7.34%
Immuneering CorporationIMRX · Biotechnology 243.51M 3.7600 +2.17%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
OS Therapies IncorporatedOSTX · Grasonville, MD 53.83M 1.1500 −0.86%
Heron Therapeutics, Inc.HRTX · Cary, NC 56.69M 0.2986 +4.88%
Boundless Bio, Inc.BOLD · San Diego, CA 55.65M 2.4000 +0.84%
Hansa Biopharma AB (publ)0RC7.IL · Lund, Sweden 58.79M 41.36 +4.82%
Arch Biopartners Inc.ARCH.V · Toronto, ON 58.42M 0.8600 −2.27%
Pliant Therapeutics, Inc.PLRX · South San Francisco, CA 52.75M 0.8518 −1.03%
iBio, Inc.IBIO · San Diego, CA 51.45M 0.8000 −2.85%
Verrica Pharmaceuticals Inc.VRCA · West Chester, PA 59.35M 3.4550 +5.02%

Also based in New York, New York, then elsewhere in New York.

Company Mkt cap Price Today
Citigroup Inc.C · New York, NYOdds 206.47B 124.74 +1.65%
Coinbase Global, Inc.COIN.BA · New York, NY 67.45T 9,435.00 +4.43%
The Bank of New York Mellon CorporationBNY.BA · New York, NY 43.07T 128,000.00 +2.58%
Verizon Communications Inc.VZ · New York, NYOdds 191.36B 46.17 +2.06%
Pfizer Inc.PFE · New York, NYOdds 175.50B 30.79 +2.63%
JPMorgan Chase & Co.JPM · New York, NYOdds 935.07B 352.11 +4.18%
Colgate-Palmolive CompanyCL.BA · New York, NY 14.28T 53,900.00 +1.60%
Morgan StanleyMS · New York, NYOdds 303.56B 193.97 +4.23%

What visitors to MiNK Therapeutics's page also look at.

Company Mkt cap Price Today
Autohome Inc.ATHM 2.59B 22.49 +12.68%
Inspire Medical Systems, Inc.INSP 1.93B 66.61 +7.61%
ZW Data Action Technologies IncCNET 3.45M 0.9402 +3.66%
Commerce.com, Inc. - Series 1CMRC 285.86M 3.4500 +4.55%
Virtus Investment Partners, IncVRTS 853.60M 128.89 +7.02%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All INKT news ›
markets.businessinsider.com·Positive

Mink Ventures Corporation Grants Stock Options

TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Mink Ventures Corporation (TSXV:MINK) (“MINK ” or the 'Company ') today announced that the Board of ... Mink Ventures Corporation Grants Stock Options TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) --…

INKTRENX
Stock Titan·

MiNK Therapeutics CEO proposes $73.3K share sale

CEO lists 6,938 shares for sale at MiNK Therapeutics (Nasdaq: INKT) following stock award vesting. Stock Titan MiNK Therapeutics CEO proposes $73.3K share sale The notice attributes the sale to obligations arising from vesting and…

KNTKPTCT
MarketScreener·

IRulya Therapeutics Inc. : Insider Transactions

Follow insider transactions on IRulya Therapeutics Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions IRulya Therapeutics Inc. Biotechnology & Medical Research Latest…

INKT
MarketScreener·

Reflect Scientific, Inc. : Insider Transactions

Follow insider transactions on Reflect Scientific, Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Reflect Scientific, Inc. Medical Equipment, Supplies &…

INKTASML

From the 4Search news index, newest first.

In the news

7mentions in 30 days
3with it in the headline
Positivesentiment

Mentioned with

Clearance of Senescent Tumor Cells6Mink Therapeutics, Inc6Mink Therapeutics, Inc.6Eli Lilly and Company3Johnson & Johnson2Merck & Co., Inc.2Mrk) Merck & Co., Inc.2Pfizer2

People in the coverage

Mitch Edgeman4Sarita Garza4Danessa Lincoln3Basaglar2Jardiance2Jennifer Buell2

Themes

Healthcare7SEC Filings6Biotechnology5Form 45Gvhd4Biotech3Insider Trades3Insider Trading3

Most coverage from

  1. marketscreener.com3
  2. investingnews.com1
  3. markets.businessinsider.com1
  4. stocktitan.net1
  5. themarketsdaily.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance